ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0463

Appropriate Preconception Care Improves Pregnancy Outcomes in SLE Patients

Hiromi Shimada1, Rina Mino2, Risa Wakiya3, Shusaku Nakashima3, Taichi Miyagi4, Yusuke Ushio5, Koichi Sugihara6, Mao Mizusaki3, Kanako Chujo7, Ryoko Kagawa5, Hayamasa Yamaguchi5, Tomohiro Kameda3 and Hiroaki Dobashi3, 1Kagawa University, Kagawa, Japan, 2Kagawa University, Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa, Japan, 3Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan, 4Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kidagun, Japan, 5Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki-cho, Kita-gun, Japan, 6Kagawa University, Miki-cho, Kita-gun, Japan, 7Kagawa University, Miki, Kita District, Kagawa, Japan

Meeting: ACR Convergence 2023

Keywords: pregnancy, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0460–0479) Reproductive Issues in Rheumatic Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Pregnancies complicated by systemic lupus erythematosus (SLE) are known to be at high risk for adverse pregnancy outcomes (APOs). Previous studies have shown that active SLE and/or glucocorticoid use were risk factors for APOs. In American College of Rheumatology guideline for reproductive health, the importance for preconception care has been indicated. However, the evidence of the need for preconception care has not well revealed, especially whether it influences pregnancy outcomes. Therefore, we evaluated the impact of preconception care for SLE patients on pregnancy outcomes.

Methods: We used the data of SLE patients who were managed from the planning for pregnancy to delivery from March 2006 to March 2023 in our institution. Preconception care strategy was defined as all of the following: 1) counseling, 2) contraception and control moderate or high disease activity, 3) assessment of risk factors for maternal and fetal adverse event, 4) change to pregnancy-compatible medications. We retrospectively evaluated the associatio

Results: 42 cases in 30 SLE patients were included in our study. The preconception care strategy was completed in 34 cases (81.0%), while the remaining cases resulted in conceiving before completion of preconception care. In preconception care group, mean glucocorticoid dose and the rate of increasing dose of glucocorticoid during pregnancy was significantly lower than non-preconception care group (Table 1, P=0.01, < 0.01). As for disease activity parameters, only SLEDAI at first trimester was significantly lower in preconception care group (Table 2, P=0.01). However, there was no significant difference in other disease activity parameters between these two groups. Table 3 showed pregnancy outcomes with or without preconception care. Mean gestational age at delivery and mean birth weight of newborns was significantly higher in preconception care group (P=0.03 and < 0.01), and the rate of APOs or NICU administration was significantly lower in these group (P=0.04 and 0.03). The rates of preterm birth, low birth weight, or SGA tend to be lower in preconception care group (P=0.06, 0.053, and 0.06).

Conclusion: In SLE patients, completing preconception care strategies improved pregnancy outcomes, by reducing glucocorticoid dose during pregnancy and controlling disease activity, especially in SLEDAI. Preconception care is an important therapeutic strategy for SLE patients who hope to pregnancy.

Supporting image 1

Table 1. Patients characteristics on preconception care. Values are presented as the mean ± standard deviation or number (%). #Wilcoxon rank sum test; ##Fisher’s exact test. *P < 0.05.

Supporting image 2

Table 2. Disease activity parameters on preconception care. Values are presented as the mean ± standard deviation or number (%). #Wilcoxon rank sum test; ##Fisher’s exact test. *P < 0.05. SLEDAI: systemic lupus disease activity index; LLDAS: low lupus disease activity status.

Supporting image 3

Table 3. Pregnancy outcomes on preconception care. Values are presented as the mean ± standard deviation or number (%). #Wilcoxon rank sum test; ##Fisher’s exact test. *P < 0.05. NICU: neonatal intensive care unit.


Disclosures: H. Shimada: None; R. Mino: None; R. Wakiya: None; S. Nakashima: None; T. Miyagi: None; Y. Ushio: None; K. Sugihara: None; M. Mizusaki: None; K. Chujo: None; R. Kagawa: None; H. Yamaguchi: None; T. Kameda: None; H. Dobashi: None.

To cite this abstract in AMA style:

Shimada H, Mino R, Wakiya R, Nakashima S, Miyagi T, Ushio Y, Sugihara K, Mizusaki M, Chujo K, Kagawa R, Yamaguchi H, Kameda T, Dobashi H. Appropriate Preconception Care Improves Pregnancy Outcomes in SLE Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/appropriate-preconception-care-improves-pregnancy-outcomes-in-sle-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/appropriate-preconception-care-improves-pregnancy-outcomes-in-sle-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology